HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates.

Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) infections have become common among both hospitalized and nonhospitalized patients. Optimal outpatient therapy for MRSA infections has yet to be determined, but this matter is complicated by the possibility of inducible macrolide-lincosamide-streptogramin B resistance (MLSBi). We studied the prevalence of MLSBi in community- and hospital-associated S. aureus isolates and the prevalence of community-associated MRSA (CA-MRSA) and identified clinical predictors of CA-MRSA and MLSBi. Among 402 S. aureus isolates, the overall prevalence of MLSBi was 52%, with 50% of MRSA and 60% of methicillin-susceptible S. aureus isolates exhibiting MLSBi. CA-MRSA represented 14% of all isolates and had a lower prevalence of MLSBi than hospital-associated MRSA (33% versus 55%). The presence of skin or soft-tissue infection was predictive for CA-MRSA, and the presence of a comorbidity was predictive for MLSBi. Due to the low prevalence of MLSBi among CA-MRSA isolates, clindamycin remains a useful option for outpatient therapy.
AuthorsMukesh Patel, Ken B Waites, Stephen A Moser, Gretchen A Cloud, Craig J Hoesley
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 44 Issue 7 Pg. 2481-4 (Jul 2006) ISSN: 0095-1137 [Print] United States
PMID16825368 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Lincosamides
  • Macrolides
  • Streptogramin B
  • Clindamycin
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Clindamycin (pharmacology)
  • Community-Acquired Infections (microbiology)
  • Cross Infection (microbiology)
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Lincosamides
  • Macrolides (pharmacology)
  • Male
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Staphylococcal Infections (microbiology)
  • Staphylococcus aureus (drug effects, isolation & purification)
  • Streptogramin B (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: